Form D · Biotechnology
Ortho-tag, Inc.
Pittsburgh, PA · CIK 0001528771
Offering snapshot reported Aug 29, 2011 · SEC filing
- Reported sold
- $1.6M Offering amount: $2M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Aug 15, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 29, 2011 | Initial | $1,600,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-165081
Source: Form D, filed Aug 29, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| J. Lee Berger | Director, Executive |
| Ken Laing | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2637 Chartiers Avenue
Pittsburgh, PA, 15204
Pittsburgh, PA, 15204